ArticleOncoTargets and therapy2016

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy.

Leonardo Muratori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.